Research at the Comprehensive Cancer Center Freiburg – CCCF
From foundations to clinical applicationsThe dual focus of our efforts is to offer our patients interdisciplinary, innovative, and comprehensive care and to promote translational cancer research.
In the context of clinical trials, we can provide patients with the earliest possible access to promising new diagnostic and therapeutic concepts. The patients in question thus benefit from novel scientific approaches. The translation of research findings into clinical trials is facilitated by the Clinical Trials Unit and by early clinical trial units (ECTU) for adults and for children.
Gastrointestinal
| AG Thimme/ Hofmann | |
| AG Bengsch | |
| AG Schmidt | Interdisciplinary gastrointestinal endoscopy |
| AG Schultheiß/ Bettinger | Clinical aspects of TIPS implantation and hepatocellular carcinoma |
| AG Quante | Pathogenesis of Barrett’s esophagus (BE) and the resulting adenocarcinoma of the esophagus (AEG) |
Hematology/Oncology
| AG Becker | |
AG DuqueAcute leukemias and allogeneic stem cell transplantation | Acute leukemias and allogeneic stem cell transplantation |
| AG Duyster | |
| AG Frew | |
AG Hartmann | Microenvironment-induced therapy resistance in leukemia and lymphoma |
AG Illert | Moleculare oncology – Signal transduction of oncogenic tyrosine kinases |
AG Köhler | Tumor immunology and T cell based immunotherapies |
| Lübbert Laboratory | Cancer Epigenetics |
| AG Pahl | Section for Molecular Hematology |
| AG Scherer | Developing improved molecular biomarkers and novel prognostic and predictive models |
| AG Zeiser | Alloimmune regulation |
Skin Tumors
| Freiburg Skin tumor Center | Malignant skin tumors: Intralesional therapies and tumor stem cells / Psycho-oncological care of skin cancer patients |
Molecular Medicine
| AG Reinheckel | In vivo functions of proteases |
| AG Brummer | Signal transduction in tumor development and drug resistance |
| Max Eder Nachwuchsgruppe | https://www.uniklinik-freiburg.de/chirurgie/forschung/max-eder-gruppe-ruess.html |
Neurosurgery
| Prof. Dr. O. Schnell | Translational NeuroOncology Research Group |
| PD Dr. D.H. Heiland | Microenvironment and Immunology Research Laboratory |
| Fr. PD Dr. M.S. Carro | Genetics of Brain Tumors Research Group |
| Fr. Prof. Dr. M. Machein | Neurooncological Health Care Research Group |
| Prof. Dr. J.-H. Klingler, Fr. Dr. C. Steiert | Hemangioblastoma and von Hippel-Lindau (VHL) Disease Research Group |
| Prof. Dr. T. Ball | Neuromedical AI Lab |
| Prof. Dr. O. Schnell, Fr. Dr. D. Cipriani | Clinical Trial Unit |
Esophageal Carcinoma
| AG Esophageal Carcinoma | Surgical treatment of the adenocarcinoma of the esophagus and the esophagogastric junction |
| Department of General and Visceral Surgery | Minimally invasive surgery for esophageal tumors |
Oncoimmunology
| Oncoimmunology Research Group | Immunological and microbial processes in the tumor microenvironment of inflammation-associated and spontaneous colorectal carcinomas. |
Oncological Theranostics
Pediatrics
AG Erlacher | |
AG Flotho | EPIdiagnosis and EPItherapy of juvenile myelomonocytic leukemia |
AG Hettmer | |
AG Kapp | |
AG Ku | |
AG Strahm | Rare Blood Disorders and Hematopoietic Stem Cell Transplantation |
AG Zieger | Inherited and acquired disorders of primary and secondary hemostasis |
Pathology
| AG Lassmann | Molecular tumor pathology |
| AG Bronsert | Malignant epithelial tumors of the gastrointestinal tract (emphasis: pancreatobiliary system) and the female sex organs (emphasis: mamma) |
| Core Facility for Histopathology and Digital Pathology | Core Facility für Histopathology and Digital Pathology |
| Biobank | Biobank of the Comprehensive Cancer Center |
| AG Schilling | Translational proteomics and proteolytic signaling |
Plastic Surgery
| AG Eisenhardt/ Braig | |
| AG Eisenhardt Diagnostics | Diagnostic biomarkers for soft tissue sarcomas |
Radiopharmaceutical Development
| AG Eder | Identification of novel radiopharmaceuticals in the field of diagnostic and therapeutic medicine |
Radiation Oncology
| Research in radiation oncology | https://www.uniklinik-freiburg.de/strahlenklinik/forschung.html |
| Baltas Research Group | Division of Medical Physics |
| AG Schäfer | Section of Radiobiology |
| AG Niedermann | Section of Radiobiology |
| AG Zamboglou | Section of Interventional Radiotherapy |
| AG Heinemnann | Clinical and Administrative Informatics Functional Area |
| AG Nicolay | Radiobiology of Mesenchymal Stem Cells Research Group |
CNS Lymphomas
PD Dr. Tanja Hartmann
Telephone: +49 (0)761 270-71511
tanja.hartmann@uniklinik-freiburg.de